• Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

The Neurologic Impact of COVID-19: Early Signs, Past Experience

Slideshow

As neurologic findings among patients with COVID-19 emerge, comparison to sequelae seen with other coronaviruses is instructive.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Related Content
FDA Grants First-in-Class Marketing Authorization for Digital Therapeutic in Episodic Migraine Prevention

FDA Grants First-in-Class Marketing Authorization for Digital Therapeutic in Episodic Migraine Prevention

Grace Halsey
April 16th 2025
Article

CT-132 is a 12-week app-based intervention that uses validated behavioral techniques to modulate labile brain circuitry involved in migraine, according to Click Therapeutics.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Gantenerumab May Delay Alzheimer Disease Symptoms in High-Risk Adults: Daily Dose / image credit: ©New Africa/AdobeStock

Gantenerumab May Delay Alzheimer Disease Symptoms in High-Risk Adults: Daily Dose

Sydney Jennings
April 10th 2025
Article

Your daily dose of the clinical news you may have missed.

Distress Signals: How to Help a Clinician Colleague in Need

Distress Signals: How to Help a Clinician Colleague in Need

Sydney Jennings
February 14th 2023
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Rebekah Bernard, MD, a family physician and national speaker on physician wellness.

Trontinemab: Roche Announces Phase 3 Development Program in Adults with Early Alzheimer Disease / image credit ©Sundry Photography

Trontinemab: Roche Announces Phase 3 Development Program for the mAb in Adults with Early Alzheimer Disease

Grace Halsey
April 7th 2025
Article

Using the proprietary Roche Brainshuttle technology, trontinemab leads to deep, rapid amyloid plaque reduction with a favorable safety profile.

For Sleep Disturbance in Alzheimer Disease, Cannabinoid-Based IGC-AD1 Shines in Phase 2

For Sleep Disturbance in Alzheimer Disease, Cannabinoid-Based IGC-AD1 Shines in Phase 2

Grace Halsey
March 27th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.